HU

Humane Genomics

YC S21 ↗

New York City, US · Founded 2019 · 5 employees · 7 known investors

humanegenomics.com ↗

Humane Genomics develops oncolytic viral therapies designed to selectively target and kill cancer cells using engineered RNA viruses, particularly Vesicular Stomatitis Virus. The company leverages a computational platform for viral genome design and engineering to create cancer treatments with improved safety, efficacy, and manufacturing efficiency.

Founders & leadership· Y Combinator alumni (S21)

PW

Peter Weijmarshausenin𝕏Founder

CM

Chad Molesin𝕏Founder

Investors · 7

20

2048 VenturesNew York · $500K – $3M

HU

Humba VenturesSan Francisco · $750K

LE

Leo Capital VenturesSingapore

LI

LifeX VenturesSan Franciscovia Inaki Berenguer · inferred

RE

Red Beard VenturesWestport · $90K – $300K

UN

Union Square Ventures (USV)New York · $1M – $20M

Y

Y CombinatorSan Francisco · $500K